G. Sfakiotaki

Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study

Christos Emmanouilides, G. Sfakiotaki, Nikolaos Androulakis et al. · BMC Cancer · 2007 · 102 citations · Full text

Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer

N. Xenidis, V. Markos, Stella Apostolaki et al. · Annals of Oncology · 2007 · 73 citations · Full text

Breast Oncology, Medicine, Immunology +11

Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy

John Souglakos, A. Kalykaki, L. Vamvakas et al. · Annals of Oncology · 2006 · 63 citations

Oncology, Phase Ii Trial, Gastrointestinal Oncology +8

Expression of Proliferating Cell Nuclear Antigen (PCNA) in Multiple Myeloma: Its Relationship to Bone Marrow Microvessel Density and other Factors of Disease Activity

Michael G. Alexandrakis, Freda Passam, Constantina A. Pappa et al. · International Journal of Immunopathology and Pharmacology · 2004 · 15 citations

A Dose Escalation Study of Gemcitabine plus Pemetrexed Administered Biweekly in Patients with Solid Tumors

A. Kalykaki, L. Vamvakas, Sofia Agelaki et al. · Oncology · 2006 · 10 citations